CLINICAL_TRIALS
trial_result
· 2014-11-24
Clinical Trial Update: Long-term Study of KAD-1229 in Type 2 Diabetes Patients [Phase 3]
Summary
A long-term Phase 3 study of KAD-1229 in patients with Type 2 diabetes mellitus has completed, with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kissei Pharmaceutical Co., Ltd. | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2014-11-24